Teachers Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Teachers Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2.58M	Buy	317,364 +11,637	+4%	+$99.6K	﹤0.01%	1824
2018 Q4	$2.47M	Buy	305,727 +10,941	+4%	+$85.1K	﹤0.01%	1723
2018 Q3	$2.25M	Buy	294,786 +11,682	+4%	+$78.5K	﹤0.01%	1915
2018 Q2	$1.62M	Buy	283,104 +11,967	+4%	+$65.9K	﹤0.01%	2081
2018 Q1	$1.29M	Buy	271,137 +1,138	+0.4%	+$5.85K	﹤0.01%	2092
2017 Q4	$1.33M	Buy	269,999 +68,120	+34%	+$330K	﹤0.01%	2086
2017 Q3	$1.06M	Buy	201,879 +5,494	+3%	+$28.1K	﹤0.01%	2201
2017 Q2	$1.09M	Buy	196,385 +70,438	+56%	+$429K	﹤0.01%	2179
2017 Q1	$1.06M	Buy	125,947 +170	+0.1%	+$1.18K	﹤0.01%	2151
2016 Q4	$796K	Buy	125,777 +19,615	+18%	+$102K	﹤0.01%	2297
2016 Q3	$468K	Sell	106,162 -11,236	-10%	-$44.9K	﹤0.01%	2500
2016 Q2	$333K	Buy	117,398 +10,364	+10%	+$32.2K	﹤0.01%	2639
2016 Q1	$303K	Sell	107,034 -311,100	-74%	-$1.38M	﹤0.01%	2611
2015 Q4	$4.32M	Hold	418,134	–	–	0.01%	1197
2015 Q3	$4.77M	Buy	418,134 +312,714	+297%	+$4.17M	0.01%	1139
2015 Q2	$1.57M	Buy	105,420 +5,346	+5%	+$60.8K	﹤0.01%	1852
2015 Q1	$904K	Buy	100,074 +1,891	+2%	+$19.6K	﹤0.01%	2101
2014 Q4	$1.19M	Hold	98,183	–	–	﹤0.01%	1928
2014 Q3	$960K	Hold	98,183	–	–	﹤0.01%	2031
2014 Q2	$1.25M	Buy	+98,183	New	+$955K	﹤0.01%	1925

Other funds holding BCRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Teachers Advisors's BCRX Position: Q1 2019 in Review

Teachers Advisors increased its BioCryst Pharmaceuticals (BCRX) stake by 3.8% in Q1 2019, buying an estimated $99.6K and bringing the position to 317,364 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

Teachers Advisors first reported a position in BCRX in Q2 2014 and has held it in 20 quarters since. The position peaked at $4.77M in Q3 2015. 133 funds tracked by Wall St. Rank hold BCRX as of Q1 2019.

Teachers Advisors held 317,364 shares of BioCryst Pharmaceuticals worth $2.58M as of Q1 2019.
Teachers Advisors bought 11,637 BioCryst Pharmaceuticals shares in Q1 2019, an estimated $99.6K.
BioCryst Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1824 holding.
Teachers Advisors first reported a position in BioCryst Pharmaceuticals in Q2 2014 and has held it in 20 quarters since.
Teachers Advisors's BioCryst Pharmaceuticals position peaked at $4.77M in Q3 2015.
133 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.